Newsroom
Newsroom
Blog Posts
We sat down with Andrea Conforto, VP of CDMO at Olon Biotech....
Industry News
Antheia, a Menlo Park, CA-based pharmaceutical ingredient manufacturer, raised $56M in Series C funding....
Industry News
Antheia, manufacturer of a major Narcan ingredient, raised a $56 million Series C round, co-founder and CEO, Christina Smolke, tells Axios....
Press Releases
New funding will support the company’s rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform....
Blog Posts
After a busy year marked by major commercial milestones for Antheia, we are excited to announce $56 million in Series C financing. With the support...
Industry News
A conversation with John Crowley, CEO, BIO, Dr. Christina Smolke, CEO, Antheia, and Dr. Jason Roos, Acting Director, ARPA-H, moderated by Dr. Kavita Berger, Director...
Industry News
Christina Smolke, CEO of Antheia featured in the sixth annual edition of In Vivo’s Rising Leaders - 30 Rising Leaders Across The Life Sciences Sector....
Industry News
A conversation with John Crowley, CEO, BIO, Dr. Christina Smolke, CEO, Antheia, and Dr. Jason Roos, Acting Director, ARPA-H, moderated by Dr. Kavita Berger, Director...
Industry News
Christina Smolke, CEO of Antheia featured in the sixth annual edition of In Vivo’s Rising Leaders - 30 Rising Leaders Across The Life Sciences Sector....
Industry News
Modern CEO reached out to executives to understand how they’re navigating tariffs, roiling markets, and more....
Industry News
Modern CEO reached out to executives to understand how they’re navigating tariffs, roiling markets, and more....
Industry News
More than 40 industry executives shared their views on where the biopharma industry stands as it enters the new year....
Industry News
The company was awarded for its ability to outperform conventional manufacturing methods for critical pharmaceutical ingredients and rapidly reach a commercial scale in the U.S....
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Heidi Pucel as its Chief People Officer....
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, today announced the appointment of Zack McGahey as Chief Operating Officer......
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a...
Press Releases
Antheia, a synthetic biology company enabling next-generation plant-inspired medicines, announced today that it has raised $73M in Series B financing. The oversubscribed round was led...
Press Releases
Today, three leading synthetic biology companies announced the launch of the Synthetic Biology (SynBio) Coalition (www.synbioco.com) to promote investment and support for the American synthetic...
Press Releases
A new paper published today in the journal Nature describes the first successful microbial biosynthesis of the tropane alkaloids hyoscyamine and scopolamine, a class of...
Blog Posts
We sat down with Andrea Conforto, VP of CDMO at Olon Biotech....